Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	297.3	242.08	399.27	276.47	869.19	397.66
Short-Term Investments	1,993	2,056	1,932	1,710	1,246	1,495
Cash & Short-Term Investments	2,290	2,298	2,331	1,987	2,115	1,892
Cash Growth	10.17%	-1.44%	17.33%	-6.06%	11.76%	-24.29%
Accounts Receivable	52.58	92.19	97.78	25.54	61.9	76.2
Inventory	8.48	12.51	7.44	22.03	24.81	21.97
Other Current Assets	226.11	217.93	205.43	168.25	143.37	140.16
Total Current Assets	2,577	2,620	2,642	2,203	2,345	2,131
Net Property, Plant & Equipment	275.88	256.11	242.94	255.84	196.04	181.08
Other Intangible Assets	-	-	-	-	-	27.94
Other Long-Term Assets	132.1	127.28	105.28	75.34	70.6	50.03
Total Assets	2,985	3,004	2,990	2,534	2,612	2,390
Accounts Payable	22.8	42.96	26.03	17.92	11.9	17.2
Accrued Expenses	145.52	178.05	215.62	189.28	127.37	155.89
Current Portion of Long-Term Debt	630.12	-	44.33	-	-	316.11
Unearned Revenue	75.91	78.99	151.13	90.58	97.71	108.38
Other Current Liabilities	22.89	9.31	10.98	13.78	3.56	1.32
Total Current Liabilities	897.24	309.32	448.09	311.56	240.55	598.9
Long-Term Debt	566.42	1,194	1,188	1,167	1,221	600.12
Long-Term Leases	164.38	161.81	170.88	178.94	19.43	-
Other Long-Term Liabilities	666.3	698.72	754.92	287.77	351.88	424.05
Total Long-Term Liabilities	59.07	51.92	41.84	15.97	6.95	23.41
Total Liabilities	2,353	2,415	2,603	1,961	1,840	1,646
Common Stock	0.16	0.16	0.14	0.14	0.14	0.14
Additional Paid-in Capital	2,933	2,869	2,215	2,060	1,964	1,896
Accumulated Other Comprehensive Income	-27.99	-30.81	-32.65	-57.48	-32.67	-21.07
Retained Earnings	-2,273	-2,250	-1,796	-1,430	-1,160	-1,131
Total Common Shareholders' Equity	631.72	588.35	386.69	572.89	771.74	743.28
Shareholders' Equity	631.72	588.35	386.69	572.89	771.74	743.28
Total Liabilities & Equity	2,985	3,004	2,990	2,534	2,612	2,390
Total Debt	1,361	1,355	1,403	1,346	1,241	916.23
Net Cash (Debt)	929.06	942.29	928.33	641.18	874.4	976.15
Net Cash Growth	-1.40%	1.50%	44.78%	-26.67%	-10.42%	-43.50%
Net Cash Per Share	5.74	6.30	6.48	4.52	6.20	6.99
Book Value	631.72	588.35	386.69	572.89	771.74	743.28
Book Value Per Share	3.90	3.94	2.70	4.04	5.47	5.32
Tangible Book Value	631.72	588.35	386.69	572.89	771.74	715.35
Tangible Book Value Per Share	3.90	3.94	2.70	4.04	5.47	5.12

Updated Jul 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q